Welcome to MyStrategist, the digital home for Market Pathways.

Market Pathways covers the people, challenges, and opportunities impacting the global medtech regulatory, reimbursement, and policy communities. We invite you to explore our coverage. Think Strategically. Subscribe Today

Browse   Latest Issue

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Subscribe
View More
View More
Teaser Image
Regulatory & Reimbursement

CDRH Departures and Delays, Medtech Tariffs Pushback, and More

  • 5 days ago
  • David Filmore

In this week’s Pathways Picks: More scientists and reviewers are leaving FDA’s device center, and at least one prominent device lawyer says their departures have already caused tangible delays; CMS plans Parkinson’s and tremors device coverage meeting; US and Europe medtech groups align on message to zero out medtech tariffs; German insurers seek digital health reforms; and more from the US, Norway, and China.

Subscribe

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Subscribe
View More
View More
Teaser Image
Regulatory & Reimbursement

CDRH Departures and Delays, Medtech Tariffs Pushback, and More

  • 5 days ago
  • David Filmore

In this week’s Pathways Picks: More scientists and reviewers are leaving FDA’s device center, and at least one prominent device lawyer says their departures have already caused tangible delays; CMS plans Parkinson’s and tremors device coverage meeting; US and Europe medtech groups align on message to zero out medtech tariffs; German insurers seek digital health reforms; and more from the US, Norway, and China.

Subscribe

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More
Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Subscribe
View More
View More
Teaser Image
Regulatory & Reimbursement

What’s Happening at CDRH? RIFs, Retirements, User Fees, and Unknowns

  • 3 days ago
  • David Filmore

FDA’s device center lost more than 200 people in the large-scale reduction-in-force action advanced April 1, and many more have left in a steady stream of retirements and resignations under pressure by the Trump administration. Here’s a roundup of what we know about the people and functions lost at CDRH, and possible next shoes to drop, including review impacts and user-fee program risks. (Pictured: Building 66, FDA's White Oak Campus) Updated May 1

Subscribe

Discover the people, technologies, and companies in the global medical device industry that will impact your corporate strategy with MedTech Strategist.

Subscribe Now   Learn More